pubmed-article:21779359 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C1332717 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C1706438 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C0085358 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C0018133 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C0011155 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C0281604 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C1413244 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C2698600 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C1141628 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C0127400 | lld:lifeskim |
pubmed-article:21779359 | lifeskim:mentions | umls-concept:C1292733 | lld:lifeskim |
pubmed-article:21779359 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:21779359 | pubmed:dateCreated | 2011-7-22 | lld:pubmed |
pubmed-article:21779359 | pubmed:abstractText | Graft-versus-host disease (GVHD) remains the main barrier to broader application of allogeneic hematopoietic stem cell transplantation (alloSCT) as a curative therapy for host malignancy. GVHD is mediated by allogeneic T cells directed against histocompatibility antigens expressed by host tissues. Based on previous studies, we postulated that the integrin CD103 is required for CD8-mediated GVHD, but not for graft-versus-tumor effects (GVT). | lld:pubmed |
pubmed-article:21779359 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:language | eng | lld:pubmed |
pubmed-article:21779359 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21779359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21779359 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21779359 | pubmed:issn | 1932-6203 | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:DevineSteven... | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:WangJiao-Jing... | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:HadleyGregg... | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:LiuKechangK | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:HamadaniMehdi... | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:GaughanAliceA | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:AnthonyBryan... | lld:pubmed |
pubmed-article:21779359 | pubmed:author | pubmed-author:YearslyMartha... | lld:pubmed |
pubmed-article:21779359 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21779359 | pubmed:volume | 6 | lld:pubmed |
pubmed-article:21779359 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21779359 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21779359 | pubmed:pagination | e21968 | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:meshHeading | pubmed-meshheading:21779359... | lld:pubmed |
pubmed-article:21779359 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21779359 | pubmed:articleTitle | CD103 deficiency prevents graft-versus-host disease but spares graft-versus-tumor effects mediated by alloreactive CD8 T cells. | lld:pubmed |
pubmed-article:21779359 | pubmed:affiliation | Department of Microbiology and Immunology, University of Maryland Medical School, Baltimore, Maryland, United States of America. | lld:pubmed |
pubmed-article:21779359 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21779359 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
entrez-gene:16407 | entrezgene:pubmed | pubmed-article:21779359 | lld:entrezgene |